Beijing Succeeder Technology Inc.

Beijing Succeeder Technology Inc. (hereafter called SUCCEEDER), locates in Life Science Park in Beijing China, founded in 2003, SUCCEEDER specialized in thrombosis and hemostasis diagnostic products for globally market.

As one of the leading brands in China Diagnostic market of Thrombosis and Hemostasis, SUCCEEDER has experienced teams of R&D, Production, Marketing, Sales and Service, Supplying coagulation analyzers and reagents, blood rheology analyzers, ESR and HCT analyzers, platelet aggregation analyzers, with ISO 13485, CE Certification, and FDA listed.

Succeeder’s core technology covering instruments, reagents and consumables has been formed, with outstanding independent R&D and technological innovation capabilities. At present, it has five core technology categories: blood rheology measurement technology platform, blood coagulation diagnostic test technology platform, biological raw material technology platform, core technology of coagulation diagnostic reagents, and traceability methods.

(1) Improving the measurement technology and automation level of existing coagulation testers and blood rheology testers;

(2) R&D Coagulation line, high-speed automatic blood coagulation tester, high-speed automatic blood rheology tester, automatic platelet function analyzer and thromboelasticity chart and other series of products;

(3) Realize independent production of upstream key raw materials, relying on biological raw material technology platform, Improve the quality and performance of reagent products;

(4) Develop vWF, LA, PC, PS, Anti-Xa, diluted thrombin time measurement (dTT), blood coagulation factor VIII and blood coagulation factor IX and other in vitro diagnostic reagents and supporting quality control Products and standard products meet the clinical needs for diagnosis and monitoring of thrombus, antiphospholipid syndrome, hemophilia and other diseases, and maintain Succeeder's professional advantages in the field of in vitro diagnosis of thrombosis and hemostasis.